Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01432691
Other study ID # 19761979
Secondary ID
Status Completed
Phase Phase 4
First received September 9, 2011
Last updated April 17, 2017
Start date June 2010
Est. completion date June 2015

Study information

Verified date April 2017
Source Hvidovre University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a Randomized Controlled Trial study comparing hemialloplastik versus total joint replacement.


Description:

Seventy patients over seventy years who are admitted in our hip fracture department with the indication for hemi joint replacement therapy, due to a Garden 3-4 femoral neck fracture or a fracture Garden 1-2 with over 20-degree posterior tilt are randomized to either hemialloplastik or total joint replacement. The patients are followed for 24 mouths with X-ray Stereo Photogrammetric Analysis (RSA) radiographs and clinical examinations.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date June 2015
Est. primary completion date June 2011
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria:

- Patients over 70 years, admitted two our hip-fracture department with a 3-4 Garden femoral neck fracture or a fracture Garden 1-2 with over 20-degree posterior tilt.

- Preoperative New Mobility Score = 6th

- Patients must be able to speak and understand Danish.

- Patients must be able to give informed consent and be cognitively intact (Hindsøe score = 6).

- Patients should be expected to be able to implement the postoperative controls. Patients should not be medically ill: ASA-score = 3rd

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Hemi (hemialloplastik)
THA vs hemi

Locations

Country Name City State
Denmark Hvidovre University Hospital, Copenhagen Copenhagen Hvidovre

Sponsors (1)

Lead Sponsor Collaborator
Hvidovre University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Radiographic and clinical Migration / rotation: Migration is measured by X-ray Stereo Photogrammetric Analysis (RSA).
Clinical assessment: The patient is assessed clinically using the WOMAC and EQ-5D.
Five years
Secondary Clinical Implant Placement:
Mobilisation: Patient mobilization level before the fracture is assessed by the New Mobility Score.Under hospital assessed patients' ability to time with current time instrument daily using the Cumulated ambulation score (CAS).
Bleeding: Perioperative bleeding set in operation description from start to suture the incision closed. Hgb is measured as standard on the third day in all patients in the hip fracture unit. In addition, registered the need for blood transfusions in the first four postoperative days.
Five years
See also
  Status Clinical Trial Phase
Recruiting NCT06214611 - Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors N/A